Tag Archive for: orthopedics

Without consumer health and with its orthopedics business undergoing restructuring, pressure on J&J’s large pharmaceutical unit is likely to intensify as the company aims to reach its goal of $57 billion in drug sales by 2025.

J&J is heading into the remainder of 2023 with a new look and a revised outlook.